TXN and lymphoma: The Tg(act-TRX1)+/0 mice had higher levels of the ASK1/Trx1 complex, reduced JNK activation, reduced oxidative damage to lipids and proteins, and had a higher incidence of total fatal tumors and fatal lymphoma compared to wild-type mice.